Gastric
by Open Maps
1. IHC
1.1. CK7
1.2. Differentiation
1.3. Overexpression
1.3.1. HER2
1.3.2. MET
2. Mutations
3. Gene fusion
3.1. ROS1
4. CNV CGH
4.1. Amplifications
4.1.1. MET
4.1.1.1. 26404902
4.2. Deletions
5. Exome
6. Targeted therapy
6.1. ERBB2
6.1.1. trastuzumab
6.2. VEGFR2
6.2.1. ramucirumab
6.2.2. apatinib
6.3. MET
6.3.1. crizotinib